Multiple Sclerosis Trial, By Invitation NCT07636876 Sponsor: Fondazione Italiana Sclerosi Multipla Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, By Invitation

NCT07636876
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with definite or probable multiple sclerosis.
  • People who have been diagnosed with CIS (clinically isolated syndrome) or RIS (radiologically isolated syndrome), which are early or incidental signs that may be related to multiple sclerosis.
  • People who have been diagnosed with NMOSD (neuromyelitis optica spectrum disorder) or MOGAD (myelin oligodendrocyte glycoprotein antibody-associated disease), which are conditions that affect the nerves of the eyes and spinal cord.
  • People who are able to understand and sign a consent form agreeing to take part in the study.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • No exclusion criteria have been listed for this trial (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 17 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Fondazione Italiana Sclerosi Multipla
Registry
ClinicalTrials.gov
Start date
17 September 2014
Est. completion
1 July 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Number of cases included; Description of demographic characteristics; Description of demographic characteristics; Description of demographic characteristics; Expanded Disability Status Scale (EDSS); Disease-modifying treatment description; Disease-modifying treatment description; Disease-modifying treatment description; Magnetic Resonance Imaging (MRI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 17 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov